Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Biomarkers in Stratifying Patients Referred Via the Lower Gastro-intestinal (LGI) Suspected Cancer Two-week Wait (2WW) Pathway

NCT07035691 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT07035691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07035691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Biomarkers in Stratifying Patients Referred Via the Lower Gastro-intestinal (LGI) Suspected Cancer Two-week Wait (2WW) Pathway
Lead sponsor
Queen Mary University of London
Phase
Observational
Overall status
Recruiting
Start date
June 30, 2025
Completion date
August 31, 2027
Enrollment
582 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenoma, colorectal carcinoma, polyp